Purpose To evaluate the in vitro inactivation of severe acute respiratory syndrome
coronavirus 2 (SARS‐CoV‐2) with hydrogen peroxide (H2O2) and povidone‐iodine (PVP‐I) …

Purpose To investigate the optimal contact time and concentration for viricidal activity of oral
preparation of povidone‐iodine (PVP‐I) against SARS‐CoV‐2 ('corona virus') to mitigate the …

Aims: Comparative evaluation of the effectiveness of the current'gold standard'chlorhexidine
and povidone iodine as a control agent, through an in-vitro analysis. Settings and Design: In …

The Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) is a novel
coronavirus first identified in Wuhan, China, and the etiological agent of Coronavirus …

SARS CoV 2 is very much homologous in structure to SARS CoV. Review of literature
suggests the in-vitro virucidal action of povidone iodine in SARS CoV and MERS. The …

Background Many people infected with severe acute respiratory syndrome coronavirus 2
(SARS-CoV-2) never develop substantial symptoms. With more than 34 million people in the …

Introduction: Severe acute respiratory syndrome-coronavirus 2 (SARS-CoV-2) is the
pathogen responsible for the global pandemic of coronavirus disease 2019 (COVID-19) …

The recent severe acute respiratory syndrome (SARS) epidemic in Asia and Northern
America led to broad use of various types of disinfectant in order to control the public spread …

ABSTRACT Unlabelled Image Background Severe acute respiratory syndrome, or SARS,
which has created panic in Asia and in some parts of North America, is the first epidemic of …

The efficacy of several povidone-iodine (PVP-I) products, a number of other chemical agents
and various physical conditions were evaluated for their ability to inactivate the severe acute …